Search

Your search keyword '"Maezawa I"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Maezawa I" Remove constraint Author: "Maezawa I"
89 results on '"Maezawa I"'

Search Results

Catalog

Books, media, physical & digital resources

5. MeCP2 modulates gene expression pathways in astrocytes

6. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome

7. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity

8. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice

10. Unique N-glycosylation signatures in Aβ oligomer-and lipopolysaccharide-activated human iPSC-derived microglia.

11. Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity.

12. Effects of Sex and Western Diet on Spatial Lipidomic Profiles for the Hippocampus, Cortex, and Corpus Callosum in Mice Using MALDI MSI.

13. The impact of mild episodic ketosis on microglia and hippocampal long-term depression in 5xFAD mice.

14. Elevated lipopolysaccharide binding protein in Alzheimer's disease patients with APOE3/E3 but not APOE3/E4 genotype.

15. Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer's mouse model and stimulates synaptic plasticity pathway enzymes.

16. The ketone body β-hydroxybutyrate shifts microglial metabolism and suppresses amyloid-β oligomer-induced inflammation in human microglia.

17. Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line.

18. Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease.

19. The role of FUT8-catalyzed core fucosylation in Alzheimer's amyloid-β oligomer-induced activation of human microglia.

20. Regio-Specific N-Glycome and N-Glycoproteome Map of the Elderly Human Brain With and Without Alzheimer's Disease.

21. Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume.

22. High-Density Lipoprotein Changes in Alzheimer's Disease Are APOE Genotype-Specific.

23. Novel Stilbene-Nitroxyl Hybrid Compounds Display Discrete Modulation of Amyloid Beta Toxicity and Structure.

24. Glycosylation alterations in serum of Alzheimer's disease patients show widespread changes in N -glycosylation of proteins related to immune function, inflammation, and lipoprotein metabolism.

25. 1700 nm optical coherence microscopy enables minimally invasive, label-free, in vivo optical biopsy deep in the mouse brain.

26. Dysregulated bile acid receptor-mediated signaling and IL-17A induction are implicated in diet-associated hepatic health and cognitive function.

27. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia.

28. Metabolic flux analysis of the neural cell glycocalyx reveals differential utilization of monosaccharides.

29. Intellectual and Developmental Disabilities Research Centers: A Multidisciplinary Approach to Understand the Pathogenesis of Methyl-CpG Binding Protein 2-related Disorders.

31. Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease.

32. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo.

33. A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta.

34. Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity.

35. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

36. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome.

37. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.

38. CX 3 CR1 ablation ameliorates motor and respiratory dysfunctions and improves survival of a Rett syndrome mouse model.

39. Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia.

40. A Metal-Free Method for Producing MRI Contrast at Amyloid-β.

41. The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.

42. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.

43. Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

44. Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's Disease.

45. Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.

46. Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity.

47. Syntheses of 3-[(Alkylamino)methylene]-6-methylpyridine-2,4(1 H ,3 H )-diones, 3-Substituted 7-Methyl-2 H -pyrano[3,2- c ]pyridine-2,5(6 H )-dione Fluorescence Probes, and Tetrahydro-1 H ,9 H -2,10-dioxa-9-azaanthracen-1-ones.

48. Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines.

49. Synthesis and functional survey of new Tacrine analogs modified with nitroxides or their precursors.

50. Inhibition of Acyl-CoA: cholesterol acyltransferase (ACAT), overexpression of cholesterol transporter gene, and protection of amyloid β (Aβ) oligomers-induced neuronal cell death by tricyclic pyrone molecules.